Member Info for Jonnyr

MrIndia, who are you expecting with buy hemo shares?

*Vlad not class

I know many of you believe hemo’s future is entirely in hemo/class hands whereas I believe it’s about net flows in to biotech (as much as the science) . With that in mind I copied this from “the daily rip”

…..

There are three charts that the community has been talking about recently, so we want to highlight them below with some context.

The first is the market-cap weighted iShares Biotech ETF ($IBB).

Technical analysts have pointed to the base it formed throughout 2022, with prices staying below the 135-137 level. But as of this week, many suggest a breakout is ahead for the sector as prices test that resistance level once again.

So why does this matter?

Bulls say the Biotech sector is often a leading indicator for bull markets. The theory is this higher-beta area of the market shows investor risk appetite and willingness to bet on higher prices for the overall stock market. Bears question that theory and think this breakout attempt will fail like all the last as the overall market turns lower again.

Only time will tell who is right. But for now, Biotech remains on many community members’ radars. ??

Thank you dhub

*aren't

dhub, can you educate me? how do you know they are sell?

MRIndia, even if every last one of us on this board was positive the sp wouldn't go up. What drives the sp is more buyers than sellers and we need buyers who want 10's of millions of shares, not a few hundred 000 or even a couple of million. its serious buyers you want, not us PIs

Thank you jhfh.
I do believe the tide will turn and I’m daring to hope quite soon. I haven’t an effing clue what the boe and fed are doing raising interest rates, it’s a supply side issue not a demand side as far as I can see and when they realise that and stop driving us in to recession the money will flow back in.
Also people are nervous of tech and so I hope they look to biotech for big gains. I am hopeful 2023 will be a good year for us

Jhfh,
Yes marker are another one of my choices that I regret. Sticking with them as I’m 80% down there and frankly I see them as little more than a lottery ticket now.
My experience with them and others does lead me to believe that the tide is going out on equity generally and small biotech particularly and almost nothing hemo does will have a big impact atm.
In short I wait for the tide to change (money flows in to small biotech) and then we might be rewarded for progress.

I would add that as I’m sat on 3M shares and 70% down I would be ecstatic to be proved ‘wrong’

Hemo truth,
Ind status on their pancreatic cancer drug did absolutely nothing for the marker therapeutics share price. I think all this re rate talk here is hopeful, not a certainty at all. :-(

There’s an awful lot of nonsense spouted on this board. Some facts for the dreamers:
1. Re rates occur when there are substantially more buyers than sellers
2. A great rns won’t cause the sp to change unless it brings in more buyers
3. Money is flowing out of stocks atm, not in. QE has finished, global recession etc
4. Small cap biotech has been out of fashion for 2 years or more
In short watch the market for a change in sentiment rather than an rns, that is a much more reliable indicator of good times ahead

Unclemal,
I feel sorry for you I really do but you can’t make sly digs eg calling chuteless clueless, then write something as incoherent as you did and not expect a response.

Llbj,
And mad has the temerity to call chute clueless! Ffs

Uncle mal
That is nonsensical…. You would have kept millions of shares even though the share will be diluted and s shareholder will be lucky to get a penny out!
Incoherent.

Dhub,
We’ve been upset and surprised more than we’ve been surprised and happy!

Mr India
I respect your faith in hemo and your large position (which I think is bigger than mine).
I do take your points but stand by my view hemo is a minnow swimming against a strong tide and the tide is more likely to turn before hemo can become a big fish. So whilst I would love vlad to pull a rabbit out of the hat I’m really hoping for investor sentiment to change

Kurt is good at spending money, not so good at making it

Mr India,
The malaise affecting hemo is affecting nearly ever other small cap biotech. When investors cycle back in to biotech the stock will run but until then nothing short of miraculous news will shift the sp significantly /permanently

Gambier, I suggest you google the definition of harangue, no one is ‘haranguing’ kurt, just voicing an opinion on a bb designed for people to share opinions